Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gynecologic Surgical Procedures | 4 | 2022 | 63 | 1.810 |
Why?
|
| Pelvic Floor Disorders | 4 | 2022 | 9 | 1.350 |
Why?
|
| Pelvic Organ Prolapse | 6 | 2023 | 27 | 1.260 |
Why?
|
| Obstetric Labor Complications | 3 | 2024 | 94 | 1.190 |
Why?
|
| Lacerations | 2 | 2019 | 34 | 1.180 |
Why?
|
| Anal Canal | 3 | 2019 | 80 | 0.920 |
Why?
|
| Delivery, Obstetric | 4 | 2024 | 250 | 0.910 |
Why?
|
| Vagina | 6 | 2023 | 196 | 0.900 |
Why?
|
| Laparoscopy | 4 | 2022 | 487 | 0.750 |
Why?
|
| Robotic Surgical Procedures | 2 | 2022 | 201 | 0.720 |
Why?
|
| Simulation Training | 1 | 2022 | 139 | 0.650 |
Why?
|
| Dilatation | 2 | 2024 | 65 | 0.640 |
Why?
|
| Documentation | 1 | 2019 | 119 | 0.580 |
Why?
|
| Pregnancy Complications | 2 | 2010 | 507 | 0.460 |
Why?
|
| Quality Improvement | 1 | 2019 | 639 | 0.420 |
Why?
|
| Pelvic Floor | 3 | 2024 | 34 | 0.410 |
Why?
|
| Emotional Intelligence | 1 | 2012 | 14 | 0.400 |
Why?
|
| Achievement | 1 | 2012 | 31 | 0.400 |
Why?
|
| Labor Pain | 1 | 2012 | 3 | 0.400 |
Why?
|
| Analgesia, Epidural | 1 | 2012 | 27 | 0.390 |
Why?
|
| Valsalva Maneuver | 1 | 2011 | 10 | 0.380 |
Why?
|
| Labor, Obstetric | 1 | 2012 | 94 | 0.370 |
Why?
|
| Patient Admission | 1 | 2012 | 187 | 0.360 |
Why?
|
| Cardiotocography | 1 | 2010 | 19 | 0.340 |
Why?
|
| Gynecology | 3 | 2024 | 123 | 0.340 |
Why?
|
| Obstetrics | 3 | 2024 | 237 | 0.330 |
Why?
|
| Intraoperative Care | 1 | 2010 | 105 | 0.330 |
Why?
|
| Computer Simulation | 2 | 2022 | 644 | 0.320 |
Why?
|
| Abdomen, Acute | 1 | 2008 | 14 | 0.310 |
Why?
|
| Pregnancy | 9 | 2024 | 7172 | 0.310 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 442 | 0.310 |
Why?
|
| Female | 28 | 2024 | 66575 | 0.300 |
Why?
|
| Parturition | 2 | 2018 | 63 | 0.280 |
Why?
|
| Endometrial Hyperplasia | 1 | 2005 | 18 | 0.240 |
Why?
|
| Salpingectomy | 2 | 2016 | 13 | 0.240 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 87 | 0.240 |
Why?
|
| Adult | 17 | 2024 | 29482 | 0.230 |
Why?
|
| Humans | 35 | 2024 | 124809 | 0.230 |
Why?
|
| Supreme Court Decisions | 1 | 2024 | 14 | 0.230 |
Why?
|
| Prospective Studies | 7 | 2022 | 6138 | 0.230 |
Why?
|
| Endometrial Neoplasms | 1 | 2005 | 98 | 0.220 |
Why?
|
| Menopause | 1 | 2023 | 75 | 0.210 |
Why?
|
| Hysterectomy | 3 | 2023 | 192 | 0.210 |
Why?
|
| Hyaluronic Acid | 1 | 2023 | 95 | 0.200 |
Why?
|
| Suture Techniques | 3 | 2019 | 196 | 0.200 |
Why?
|
| Surgical Mesh | 1 | 2022 | 62 | 0.190 |
Why?
|
| Urinary Incontinence | 1 | 2022 | 70 | 0.190 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 796 | 0.190 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 879 | 0.180 |
Why?
|
| Urinary Retention | 1 | 2021 | 18 | 0.180 |
Why?
|
| Medicare | 1 | 2023 | 424 | 0.170 |
Why?
|
| Internship and Residency | 3 | 2024 | 1178 | 0.170 |
Why?
|
| Hospitals, Private | 1 | 2019 | 18 | 0.160 |
Why?
|
| Sperm Count | 2 | 1998 | 78 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 1109 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 431 | 0.160 |
Why?
|
| Motor Neurons | 1 | 2019 | 142 | 0.150 |
Why?
|
| Colectomy | 1 | 2019 | 76 | 0.150 |
Why?
|
| Rupture | 1 | 2018 | 32 | 0.150 |
Why?
|
| Ileum | 1 | 2019 | 132 | 0.150 |
Why?
|
| Safety-net Providers | 1 | 2019 | 52 | 0.150 |
Why?
|
| Rectum | 1 | 2019 | 99 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2024 | 1402 | 0.150 |
Why?
|
| Labor Stage, First | 1 | 2017 | 7 | 0.150 |
Why?
|
| Elasticity | 1 | 2018 | 91 | 0.150 |
Why?
|
| Surveys and Questionnaires | 6 | 2024 | 3729 | 0.150 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 257 | 0.150 |
Why?
|
| Constipation | 1 | 2019 | 115 | 0.150 |
Why?
|
| Perineum | 1 | 2018 | 48 | 0.150 |
Why?
|
| Action Potentials | 1 | 2019 | 501 | 0.130 |
Why?
|
| Ovariectomy | 1 | 2016 | 183 | 0.130 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2016 | 28 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 607 | 0.120 |
Why?
|
| Mothers | 1 | 2018 | 354 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2018 | 762 | 0.120 |
Why?
|
| Young Adult | 3 | 2024 | 8991 | 0.120 |
Why?
|
| Middle Aged | 10 | 2021 | 26727 | 0.120 |
Why?
|
| Suburethral Slings | 1 | 2014 | 6 | 0.110 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2014 | 31 | 0.110 |
Why?
|
| Urethra | 1 | 2014 | 84 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2024 | 930 | 0.110 |
Why?
|
| Quality of Life | 1 | 2023 | 1949 | 0.110 |
Why?
|
| Retrospective Studies | 7 | 2023 | 16294 | 0.100 |
Why?
|
| Organization and Administration | 1 | 2012 | 4 | 0.100 |
Why?
|
| Models, Biological | 1 | 2017 | 1461 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 418 | 0.100 |
Why?
|
| Aging | 1 | 2019 | 1189 | 0.100 |
Why?
|
| Cultural Characteristics | 1 | 2012 | 40 | 0.100 |
Why?
|
| Electronic Health Records | 1 | 2019 | 725 | 0.100 |
Why?
|
| Acculturation | 1 | 2012 | 68 | 0.090 |
Why?
|
| Cultural Competency | 1 | 2012 | 51 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2022 | 12341 | 0.090 |
Why?
|
| Vulvar Diseases | 1 | 2010 | 12 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2000 | 52 | 0.080 |
Why?
|
| Aged | 7 | 2023 | 19693 | 0.080 |
Why?
|
| Prenatal Care | 1 | 2012 | 348 | 0.080 |
Why?
|
| Canada | 1 | 2010 | 300 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3447 | 0.080 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 41 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 368 | 0.080 |
Why?
|
| Biliary Tract Diseases | 1 | 2008 | 34 | 0.080 |
Why?
|
| Abscess | 1 | 2010 | 139 | 0.080 |
Why?
|
| Piperazines | 2 | 2000 | 238 | 0.070 |
Why?
|
| Safety | 1 | 2008 | 219 | 0.070 |
Why?
|
| Pancreatitis | 1 | 2008 | 128 | 0.070 |
Why?
|
| Erectile Dysfunction | 2 | 2000 | 181 | 0.070 |
Why?
|
| Appendicitis | 1 | 2008 | 129 | 0.070 |
Why?
|
| Internet | 1 | 2010 | 383 | 0.070 |
Why?
|
| United States | 3 | 2024 | 10875 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 159 | 0.060 |
Why?
|
| Parity | 1 | 2024 | 78 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 1090 | 0.060 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2023 | 14 | 0.050 |
Why?
|
| Accreditation | 1 | 2024 | 87 | 0.050 |
Why?
|
| Dehydroepiandrosterone | 1 | 2023 | 18 | 0.050 |
Why?
|
| Women's Health | 1 | 2024 | 133 | 0.050 |
Why?
|
| Prolapse | 1 | 2022 | 11 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2024 | 998 | 0.050 |
Why?
|
| Endometrium | 1 | 2005 | 282 | 0.050 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 171 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1691 | 0.050 |
Why?
|
| Time Factors | 1 | 2011 | 6312 | 0.050 |
Why?
|
| Private Sector | 1 | 2021 | 24 | 0.050 |
Why?
|
| Appointments and Schedules | 1 | 2021 | 49 | 0.050 |
Why?
|
| Hospitals, Public | 1 | 2021 | 40 | 0.040 |
Why?
|
| Adolescent | 1 | 2019 | 19331 | 0.040 |
Why?
|
| Estrogens | 1 | 2023 | 515 | 0.040 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2021 | 72 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2021 | 73 | 0.040 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2000 | 34 | 0.040 |
Why?
|
| Urology | 1 | 2021 | 75 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2021 | 358 | 0.040 |
Why?
|
| Defecography | 1 | 2019 | 2 | 0.040 |
Why?
|
| Psychometrics | 1 | 2023 | 676 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 515 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 2019 | 21 | 0.040 |
Why?
|
| Electromyography | 1 | 2019 | 165 | 0.040 |
Why?
|
| Spermatogenesis | 1 | 2000 | 171 | 0.040 |
Why?
|
| Oligospermia | 1 | 1998 | 57 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2019 | 187 | 0.040 |
Why?
|
| Vasovasostomy | 1 | 1998 | 23 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 227 | 0.040 |
Why?
|
| Epididymis | 1 | 1998 | 54 | 0.040 |
Why?
|
| Sacrum | 1 | 2018 | 30 | 0.040 |
Why?
|
| Viscosity | 1 | 2018 | 36 | 0.040 |
Why?
|
| Geography | 1 | 1998 | 110 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 168 | 0.040 |
Why?
|
| Microsurgery | 1 | 1998 | 68 | 0.040 |
Why?
|
| Testosterone | 1 | 2023 | 538 | 0.040 |
Why?
|
| Prostatectomy | 1 | 1999 | 344 | 0.040 |
Why?
|
| Testis | 1 | 2000 | 412 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1527 | 0.040 |
Why?
|
| Infertility, Male | 1 | 2000 | 263 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2000 | 311 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 606 | 0.030 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 35 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2883 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 848 | 0.030 |
Why?
|
| Male | 8 | 2024 | 61306 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 1192 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 953 | 0.030 |
Why?
|
| Patient Selection | 1 | 2016 | 692 | 0.030 |
Why?
|
| Texas | 1 | 2021 | 3591 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 471 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2091 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 1252 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2022 | 3067 | 0.020 |
Why?
|
| Sildenafil Citrate | 2 | 2000 | 56 | 0.020 |
Why?
|
| Sulfones | 2 | 2000 | 71 | 0.020 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2010 | 27 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2820 | 0.020 |
Why?
|
| Cellulitis | 1 | 2010 | 64 | 0.020 |
Why?
|
| Purines | 2 | 2000 | 114 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2010 | 202 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 222 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6522 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 3436 | 0.020 |
Why?
|
| Reoperation | 1 | 2010 | 833 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 558 | 0.010 |
Why?
|
| Length of Stay | 1 | 2010 | 1310 | 0.010 |
Why?
|
| Flushing | 1 | 2000 | 5 | 0.010 |
Why?
|
| Ejaculation | 1 | 2000 | 20 | 0.010 |
Why?
|
| Dizziness | 1 | 2000 | 27 | 0.010 |
Why?
|
| Nose | 1 | 2000 | 92 | 0.010 |
Why?
|
| Headache | 1 | 2000 | 109 | 0.010 |
Why?
|
| Dyspepsia | 1 | 2000 | 101 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 2000 | 122 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2000 | 141 | 0.010 |
Why?
|
| Testicular Diseases | 1 | 1998 | 12 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 2427 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2000 | 224 | 0.010 |
Why?
|
| Biopsy | 1 | 2000 | 1239 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 10274 | 0.010 |
Why?
|
| Logistic Models | 1 | 2000 | 1811 | 0.010 |
Why?
|
| Incidence | 1 | 2000 | 3144 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1998 | 5155 | 0.010 |
Why?
|
| Prognosis | 1 | 1998 | 4615 | 0.010 |
Why?
|